BIRC5 and ovarian cancer: It has previously been shown that genetic deletion of survivin gene by a gene-editing technology system using clustered regularly interspaced palindromic repeats and the Cas9 enzyme (CRISPR/Cas9) in orthotopic ovarian cancer mouse models prevented tumor metastasis (70).